Assessment of Anticancer Drug Utilization Pattern from a hospital-based cancer registry—A Single Center Experience from Saudi Arabia

In recent years, various advancements in anticancer therapy have led to the development of multiple regimens and protocols. This study endeavors to provide an extensive evaluation of anticancer therapy prescription patterns from a hospital-based cancer registry. Materials and Methods: From June 2014 to April 2022, 512 adult cancer patients who received chemotherapy in our cancer center were included in a retrospective study. Data encompassed demographic characteristics of patients and cancer, chemotherapy protocols or agents, antiemetics, and drug side effects. The prescribed drugs were assessed using the Essential Medicines List (EML), while the prescription’s rationality was determined using the World Health Organization (WHO) indicators.近年来，抗癌治疗领域的多项技术进展推动了多种治疗方案与诊疗规程的发展。本研究旨在基于医院癌症登记数据库，对抗癌治疗的处方模式开展全面评估。 资料与方法：本回顾性研究纳入了2014年6月至2022年4月期间，在本癌症中心接受化疗的512例成年癌症患者。研究数据涵盖患者与肿瘤的人口统计学特征、化疗方案或化疗药物、止吐药物以及药物不良反应情况。研究人员采用基本药物目录（Essential Medicines List，EML）对处方药物进行评估，并通过世界卫生组织（World Health Organization，WHO）指标判定处方的合理性。